Point72 Hong Kong LTD Avalo Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.96 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.0 - $10.45 $4,770 - $16,615
-1,590 Reduced 47.29%
1,772 $1,000
Q1 2022

May 16, 2022
SELL
$7.57 - $21.72 $3,512 - $10,078
-464 Reduced 12.13%
3,362 $2,000
Q4 2021

Feb 14, 2022
SELL
$19.68 - $28.68 $14,622 - $21,309
-743 Reduced 16.26%
3,826 $7,000
Q3 2021

Nov 15, 2021
BUY
$26.16 - $40.68 $119,525 - $185,866
4,569 New
4,569 $10,000

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $118M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email